English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine MedTech
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 23:21 HKT
康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景
Aug 13, 2025 09:27 HKT
康基醫療收到由董事長鍾鳴、TPG及卡塔爾投資局(QIA)牽頭財團提出之私有化要約 助力公司實現長遠願景
Aug 13, 2025 09:27 HKT
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 12, 2025 18:53 HKT
康灃生物中期業績創紀錄 呼吸介入產品驅動收入激增162%
Aug 11, 2025 10:41 HKT
Cornerstone Robotics Completes World's First Clinical Validation of Autonomous Surgery Performed by Robot-Assisted Surgery
Aug 06, 2025 19:21 HKT
全球首例!康諾思騰手術機械人完成臨床場景下自主手術驗證
Aug 06, 2025 18:56 HKT
全球首例!康诺思腾手术机器人完成临床场景下自主手术验证
Aug 06, 2025 18:21 HKT
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
Jul 29, 2025 04:00 HKT
維立志博於聯交所主板成功上市
Jul 25, 2025 19:36 HKT
维立志博于联交所主板成功上市
Jul 25, 2025 18:00 HKT
아반토코리아, 수원 사무실 광교중앙역 인근으로 이전
Jul 24, 2025 09:00 HKT
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration
Jul 24, 2025 09:00 HKT
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
Jul 22, 2025 13:00 HKT
康哲药业携手新交所 共话新兴市场产业国际化与医药出海新范式探索
Jul 18, 2025 13:00 HKT
Cornerstone Robotics Signs MOU with NHG Health and NTU Singapore to Facilitate Accessibility of RAS to Patients in Singapore
Jul 17, 2025 18:45 HKT
康諾思騰與新加坡國立健保集團及南洋理工大學簽署三方戰略合作備忘錄
Jul 17, 2025 17:27 HKT
康诺思腾与新加坡国立健保集团及南洋理工大学签署三方战略合作备忘录
Jul 17, 2025 17:14 HKT
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today
Jul 16, 2025 15:00 HKT
耀啟新程!康哲藥業今日於新加坡交易所主板實現二次上市
Jul 15, 2025 17:05 HKT
Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: